Genovate Biotechnology Co., LTD.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.genovate-bio.com
Clinical Trials
13
Active:0
Completed:7
Trial Phases
4 Phases
Phase 1:5
Phase 2:1
Phase 3:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (50.0%)Phase 3
2 (20.0%)Phase 4
2 (20.0%)Phase 2
1 (10.0%)Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication
Phase 3
Terminated
- Conditions
- Intermittent Claudication
- Interventions
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 14
- Registration Number
- NCT06886620
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Mackay Memorial Hospital, Taipei, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR Tablet 145 mg
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 40
- Registration Number
- NCT06167265
- Locations
- 🇺🇸
Cliantha Research, Saint Petersburg, Florida, United States
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR Tablet 135 mg
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 25
- Registration Number
- NCT05466734
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Terminated
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR 135 mg
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 19
- Registration Number
- NCT05191862
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Intermittent Claudication
- Interventions
- Drug: PMR 200 mg
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- Genovate Biotechnology Co., Ltd.,
- Target Recruit Count
- 28
- Registration Number
- NCT03864666
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found